ADOXI(Docetaxel)
Therapeutic class: Microtubule inhibitor
- Breast Cancer (BC)
- Non-Small Cell Lung Cancer (NSCLC
- Hormone Refractory Prostate Cancer (HRPC)
- Gastric Adenocarcinoma (GC)
- Squamous Cell Carcinoma of the Head and Neck Cancer (SCCHN)
20 mg & 80 mg & 120 mg Injection
20 mg /0.5ml:- Sterile single dose vial with combi pack of solvent80 mg /2ml:- Sterile single dose vial with combi pack of solvent
120 mg/3ml:- Sterile single dose vial with combi pack of solvent
- 2°C to 8°C , Shelf Life: 2 Years
- As directed by physician
